Global Non-PVC IV Bags Market by Material (PP, EVA), by Product (Single Chamber, Multi Chamber), by Content (Frozen Mixture, Liquid Mixture) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global non-PVC IV bag market was worth USD 1.51 billion in 2020. It is projected to grow at a compound annual rate (CAGR), of 9.8% between 2021 and 2028. The market is driven by a rising demand for preventive measures to avoid errors such as incorrect dose delivery and an increased demand for advanced IV containers. Traditional IV containers can have problems with drug-packaging material interactions as well as difficulties in transportation, handling and disposal. Non-PVC IV bags can avoid most of these problems. The forecast period will see a rise in demand for these bags.

There is also a growing need for oncology treatment. This is because most therapeutic agents have a tendency for interaction with plasticizers and can be converted into harmful agents. Containers without plasticizers can reduce this discordancy. These bags are made from Polyester (PP), and Ethylene Vinyl Acetate. Cancer treatments can cause physical obstructions, GI dysfunction, ulcers, and nutritional deprivation. They must therefore be administered externally. Due to an increase in cancer cases, IV bags have seen a significant rise in demand.

According to the World Health Organization, cancer is the second leading cause for death in the world. The WHO stated that cancer was responsible for an estimated 9.6million deaths in 2018, or 1 in 6 deaths. According to the American Cancer Society, more than 1.7million new cases of cancer were reported in America in 2018. According to Cancer Research U.K. data, each year, 36,7000 new cases are reported in the U.K. The increasing incidence of cancer is the main factor driving the growth of the IV solutions market.

Many companies are switching to plasticizer-free, biocompatible materials to replace the use of PVC ( Polyvinyl chloride). B. Braun spent approximately USD 500.00 million over the last five years to develop innovative ways of providing DEHP-free products. Modern materials are being developed and made available in a variety of designs to increase growth. Fagron Sterile Services U.S.A (FSS), a leading 503B outsourcing company, announced that intravenous bags (IV) had been added to its product range in March 2021.

Other factors that support market growth include the expanding reach of local manufacturers on the global market, strict regulations against the disposal and usage of PVC, as well as the development of healthcare infrastructure in emerging countries. The market is also driven by technological advancements in service quality and the increased number of hospitals around the world. PVC IV bags have become a concern in the medical sector due to concerns about phthalates leaching from the equipment.

It also results in the production and release of toxic HCL from the incineration of PVC products. Acid rain is further exacerbated by this. Building IV bags, made of PVC-free material with thermal stability, moisture-barrier properties, and environmentally-friendly disposal are therefore made for companies like Baxter, Hospira, and B. Braun Melsungen AG. Healthcare can take a major step forward in safeguarding the safety and health of patients worldwide by using PVC-free IV bags.

Product Insights

In 2020, the single-chamber segment was responsible for 63% of the total revenue. As IV bags replace traditional IV containers, single-chamber products are becoming more popular. Plastic bags have replaced glass containers by non-PVC materials. This is due to their ease of use, transport, and disposal. You can also use intravenous solutions such as drip bags, irrigation fluids, and sterilized water. Single-chamber bags are therefore widely used.

Multi-chambered segments are expected to have the highest CAGR over the forecast period. When intravenous therapy is required, multi-chambered IV bags can be used. Non-PVC films with fast-seal and easy peel-off properties are used to make multi-chamber products. They are widely used in healthcare for any emergency.

These products also have the advantage of being more efficient than standard IV bags on the market. These bags are also widely used in pharmaceuticals due to their high stability, high pressure agility, exceptional transparency, toughness and thermal sealing. The multi-chambered segment is expected to grow because of the increasing product utility in multiple materials such as parenteral nutrition, drug reconstitution, and the availability customized product offerings.

Material Insights

EVS segment had the highest revenue share at 33% or more in 2020. It is expected to see significant growth during the forecast period. This is the most popular PVC alternative. It is expected to be used extensively in blood banks and storage of frozen mixtures. The segment is expected to grow due to increasing demand and recognition for blood and blood components storage, as well as an increase in blood banks.

EVA infusion bags will be more popular due to increased knowledge of parenteral nutrition therapy (PNT) and high rates of Chronic Kidney Disease. According to the CDC, more that 1 in 7 Americans, which is 15 percent of the total adult population, have CKD. This amounts to 37 million people. Compounding fluids can be administered parenterally via EVA bags. Sometimes, different medicines can be combined with ingredients or drugs.

Fluid from compounding parenteral nutrition or chemotherapy drugs, for example. The segment copolyesterether is expected to show the fastest CAGR over the projected period. Copolyesterether ether has many benefits, including transparency, durability, chemical resistance, and the ability withstand a wide range of sterilization processes such as radiation, autoclave, and electron beam.

The strength of copolyester ether can be increased by adding other materials such as PP or other polyolefins. The breakthrough in Ecdel elastomer development has been a significant moment in the evolution and use of copolyesterether in pharmaceutical packaging. These combinations are being developed by key companies such as Eastman Chemical Company, Sealed Air Corporation and B. Braun Melsungen AG.

Content Insights

The liquid mixture segment accounted for 78% of the total revenue in 2020. It will continue to hold the top spot throughout the forecast period. The high usage of IV drips in hospitals and innovative designs can explain this growth. Specialized IV containers are in high demand in blood banks. They can withstand low temperatures and provide greater security than PVC.

To increase their market share, the major players in non-PVC IV bag market are also focusing on increasing production. Grifols, for example, began production at its new blood-collection system plant in Brazil in November 2019. It has a capacity to produce more than 10,000,000 blood collection bags annually.

Non-PVC IV bags are used for frozen mix but have a very small market share. PVC bags explode at low temperatures. EVA, however, has been proven to be an alternative to PVC's lower temperatures. According to estimates, this segment will experience the fastest CAGR between 2021 and 2028. Examples of frozen mixtures include ceftriaxone and cefazolin as well as nafcillin and nicardipine hydrchloride.

Regional Insights

North America accounted for the largest revenue share, with more than 46% in 2020. The strict regulations in the United States have led to a rise in demand for non-PVC IV container, which offer safe and effective treatments. Due to stomach cancer, the demand has increased for IV bags. According to the American Cancer Society, there will be approximately 27,600 cases in 2020 of stomach cancer in America. Patients with stomach cancer cannot eat through their mouths and must rely entirely on parenteral nutrition for survival and dietary requirements. This could increase the demand for EVA bags which will in turn boost the regional market. The market is expected to grow due to the increasing adoption of new drug delivery systems and technological innovation.

Asia Pacific will be the fastest growing region market over the forecast period. Industry growth is being influenced by the rise of local manufacturers, which encourage international demand through the sale of goods at affordable prices, increased foreign direct investments, and rapid improvements in healthcare infrastructure, such as a rise in hospitals, clinics, blood banks, and other factors.

Market Share Insights & Key Companies

To strengthen their position in the global market, key players are involved in the adoption of strategies such as mergers and acquisitions, partnerships, new product launches, and partnership agreements. Baxter, for Myxredlin (the 1st and only ready to use insulin for IV Infusion), was approved by the U.S. FDA in July 2019.

To produce technologically advanced products, key players are investing heavily into R&D. Sihuan Pharmaceutical Holdings Group Ltd., a joint venture between Beijing Ruiye Drugs Manufacture Co. Ltd. and the Group, launched the "nonPVC solid-liquid double-chamber bag for ceftazidime/sodium chloride injection" in May 2019. It has been approved by the National Medical Products Administration (NMPA), People's Republic of China, for drug registration. The Group is the first group to be certified for a non-PVC solid liquid double chamber bag for ceftazidime/sodium chloride injection in China. The following are some of the most prominent players in non-PVC IV bag market:

• RENOLIT

• Baxter

• Angiplast Pvt. Ltd.

• Shanghai Xin Gen Eco-Technologies Co. Ltd.

• Jiangxi Sanxin Medtec Co.

• PolyCine GmbH

• Kraton Corp.

• B. Braun Melsungen AG

• Pfizer, Inc.

Up Market Research published a new report titled “Non-PVC IV Bags Market research report which is segmented by Material (PP, EVA), by Product (Single Chamber, Multi Chamber), by Content (Frozen Mixture, Liquid Mixture), By Players/Companies Kraton Corp, Pfizer Inc, PolyCine GmbH, RENOLIT, Jiangxi Sanxin Medtec Co Ltd, B Braun Melsungen AG, Angiplast Pvt Ltd, Baxter, Shanghai Xin Gen Eco-Technologies Co Ltd”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Non-PVC IV Bags Market Report Segments:

The market is segmented by Material (PP, EVA), by Product (Single Chamber, Multi Chamber), by Content (Frozen Mixture, Liquid Mixture).

Non-PVC IV Bags Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Non-PVC IV Bags Market

Overview of the regional outlook of the Non-PVC IV Bags Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Non-PVC IV Bags Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Non-PVC IV Bags Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. PP

                2. EVA

                1. Single Chamber

                2. Multi Chamber

                1. Frozen Mixture

                2. Liquid Mixture

9. Market scenario by region, sub-region, and country.
10. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
11. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
12. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Non-PVC IV Bags Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Non-PVC IV Bags Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.